Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 0.6%
Mon, 19 Aug 12:34

MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 0.6%Image source: DNY59/www.istockphoto.com

MARKSANS PHARMA. share price has zoomed 6% and is presently trading at Rs 221.0.

Meanwhile, the BSE HEALTHCARE index is at 41,407.5 (up 0.6%).

Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 13.5%) and POLY MEDICURE (up 7.3%).

SUVEN PHARMACEUTICALS (down 2.8%) and FORTIS HEALTHCARE (down 2.2%) are among the top losers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 113.9 to Rs 221.0, registering a gain of Rs 107.1 (up 94.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 41,407.5, registering a gain of 48.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 128.1%), Jubilant Pharmova (up 109.1%) and GSK Pharma (up 107.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,419.9 .

The top losers among the BSE Sensex today are M&M (down 2.0%) and Bharti Airtel (down 1.2%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,556.6 (up 0.1%). Hindalco and BPCL are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 80,419.9, registering a gain of 15,018.0 points (up 23.0%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit grew 26.4% YoY to Rs 891 million for the quarter ended June 2024, compared to a profit of Rs 704 million a year ago. Net sales rose 18.1% to Rs 5,906 million during the period as against Rs 5,000 million in April-June 2023.

For the year ended March 2023, MARKSANS PHARMA. reported 42.0% increase in net profit to Rs 2,653 million compared to net profit of Rs 1,868 million during FY22. Revenue of the company grew 24.2% to Rs 18,521 million during FY23.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 30.0.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 0.6%". Click here!